Not really BUT...: The class of medicine for Actonel (risedronate) is "bisphosphonates". These drugs have been associated with onj (osteonecrosis of the jaw) where the bone never heals after injury. The greatest risk for onj is in breast and prostate cancer patients who are receiving anti-cancer therapy at the same time. For the average non-cancer patient i would have no serious concerns.
Answered 3/21/2015
5.8k views
Yes: Although tooth extraction in a patient taking Actonel (risedronate) and other drugs in the "bisphosphonate" class is known to present risk of impaired bone healing-- a condition known as antiresorptive agent–induced osteonecrosis of the jaw (aronj)-- the risk has been estimated to be about 0.1%. This is indeed a very low risk-- probably lower than the risk of allowing an infected tooth to remain.
Answered 6/24/2014
5.7k views
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question